Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion evidence source_evidence_literature NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion SIO_000772 19189648 NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion wasDerivedFrom befree-2016 NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion wasGeneratedBy ECO_0000203 NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- befree-2016 importedOn "2016-02-19" NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.